Stockscreener 앱 받기
0.80%
시간 외 거래:
전일 마감가:
$687.78
열려 있는:
$692.83
하루 거래량:
1.15M
Relative Volume:
1.15
시가총액:
$88.88B
수익:
$359.05B
순이익/손실:
$3.30B
주가수익비율:
26.41
EPS:
25.83
순현금흐름:
$5.23B
1주 성능:
-5.55%
1개월 성능:
-1.69%
6개월 성능:
+11.82%
1년 성능:
+23.70%
1일 변동 폭
$676.02
$693.92
1주일 범위
$664.14
$722.12
52주 변동 폭
$464.42
$728.48
맥케슨 Stock (MCK) Company Profile
명칭
Mckesson Corporation
전화
972-446-4800
주소
6555 STATE HIGHWAY 161, IRVING, TX
MCK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
682.28 | 88.88B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
279.15 | 56.33B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
148.41 | 36.20B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
70.08 | 8.06B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
7.00 | 590.70M | 10.42B | -38.77M | 323.54M | -0.51 |
맥케슨 Stock (MCK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-04 | 재개 | Mizuho | Neutral |
| 2024-11-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | 재확인 | Leerink Partners | Outperform |
| 2024-08-08 | 재확인 | Mizuho | Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-07-06 | 다운그레이드 | Argus | Buy → Hold |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | 재확인 | Barclays | Overweight |
| 2021-11-02 | 재확인 | BofA Securities | Buy |
| 2021-11-02 | 재확인 | Evercore ISI | Outperform |
| 2021-11-02 | 재확인 | Jefferies | Buy |
| 2021-03-30 | 업그레이드 | Argus | Hold → Buy |
| 2020-11-02 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-08-04 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-05-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | 업그레이드 | UBS | Neutral → Buy |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-03-18 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-08-05 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | 개시 | Guggenheim | Neutral |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2018-10-26 | 재확인 | Barclays | Equal Weight |
| 2018-07-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-03-08 | 개시 | Barclays | Equal Weight |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-02 | 재확인 | Mizuho | Neutral |
| 2018-01-24 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
맥케슨 주식(MCK)의 최신 뉴스
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
McKesson at Bank of America Conference: Strategic Growth and Separation - Investing.com
McKesson at Bank of America Conference: Strategic Growth and Separation By Investing.com - Investing.com UK
Transcript : McKesson Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com
Here's What Key Metrics Tell Us About McKesson (MCK) Q4 Earnings - MSN
Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today - Benzinga
TD Cowen Raises Price Target for McKesson (MCK) to $820 | MCK St - GuruFocus
McKesson projects $36.75-$37.55 EPS for fiscal 2026 with oncology and biopharma growth - MSN
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Here’s Why Baron Health Care Fund Reacquired McKesson Corporation (MCK) in Q1 - Insider Monkey
TD Cowen Adjusts Price Target on McKesson to $820 From $695, Maintains Buy Rating - marketscreener.com
McKesson stock up on encouraging 2026 profit guidance - MSN
Why McKesson Stock Bumped Modestly Higher Today - AOL.com
McKesson to Spin Off Medical-Surgical Company - MSN
McKesson Set To Spin Off Med-Surg Solutions Unit - Finimize
McKesson (MCK) Price Target Raised to $800 by B of A Securities | MCK Stock News - GuruFocus
McKesson (MCK) Price Target Raised Amid Strategic Focus Shift | MCK Stock News - GuruFocus
Jefferies raises McKesson stock target to $800; maintains buy By Investing.com - Investing.com South Africa
McKesson’s Earnings Call: Record Growth Amid Challenges - TipRanks
McKesson (MCK) Stock Moves on Q4 Fiscal 2025 Earnings Report - GuruFocus
Health Care Down Sharply on Drug-Demand Fears -- Health Care Roundup - marketscreener.com
McKesson to spin-off surgical supplies business, focus on oncology - The Business Journals
McKesson's Fiscal Q4 'More Loaded Than Normal' Amid Spin-Off News, UBS Says - marketscreener.com
Jefferies raises McKesson stock target to $800; maintains buy - Investing.com
McKesson Posts 16% Annual Sales Increase; Will Divest Medical-Surgical Unit - Modern Distribution Management
Jefferies Raises Price Target on McKesson to $800 From $715, Buy Rating Kept - marketscreener.com
McKesson’s Broad-Based Growth Is Fueled by GLP-1s, Customer Win, and a Growing Specialty Portfolio - Morningstar
McKesson (NYSE:MCK) Reports US$90 Billion Sales With 66% Q4 Net Income Rise - Yahoo Finance
McKesson: Spin-Off Of Medical-Surgical Solutions Is A Positive, Strong Buy (NYSE:MCK) - Seeking Alpha
McKesson to spin off medical-surgical segment - DOTmed
McKesson Spins Off Unit To Laser In On Core Drugs - Finimize
Evercore ISI Adjusts Price Target on McKesson to $760 From $740, Maintains Outperform Rating - marketscreener.com
Baird Adjusts Price Target on McKesson to $796 From $765, Maintains Outperform Rating - marketscreener.com
Leerink Adjusts Price Target on McKesson to $785 From $745, Maintains Outperform Rating - marketscreener.com
Deutsche Bank Adjusts Price Target on McKesson to $740 From $692 - marketscreener.com
McKesson's (NYSE:MCK) investors will be pleased with their enviable 452% return over the last five years - Yahoo Finance
McKesson Corporation (NYSE:MCK) Q4 2025 Earnings Call Transcript - MSN
McKesson price target raised to $800 from $755 at BofA - TipRanks
McKesson Reports Strong Earnings and Strategic Plans - TipRanks
McKesson Corporation (NYSE:MCK) Q1 2025 Financial Results OverviewNews and Statistics - IndexBox
MCKESSON CORP SEC 10-K Report - TradingView
McKesson’s Transfer Pricing Suit Seeks to Bring Back Tax Breaks - Bloomberg Law News
McKesson Corp (MCK) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
McKesson Corp (MCK) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - GuruFocus
McKesson to separate Medical-Surgical Solutions segment as independent company - TipRanks
McKesson: Fiscal Q4 Earnings Snapshot - CT Insider
McKesson (MCK) Reports Strong Q4 2025 Performance, Plans Strategic Spin-Off - GuruFocus
McKesson Corporation 2025 Q4ResultsEarnings Call Presentation (NYSE:MCK) - Seeking Alpha
Earnings call transcript: McKesson Q3 2025 beats EPS forecasts, stock dips - Investing.com
McKesson (MCK) Expects Stronger 2026 Adjusted Profit, Shares Surge - GuruFocus
맥케슨 (MCK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
0.65%
자본화:
|
볼륨(24시간):